Trending Now
Advaxis Inc. (NASDAQ:ADXS) Receive IND Clearance From The FDA For Initiation...
Advaxis Inc. (NASDAQ:ADXS) has announced that the FDA has cleared its new Investigational New Drug Application to commence the Investigator Sponsored Phase 1 ADXS-504...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
VistaGen Therapeutics (NASDAQ:VTGN) Sign Agreement With Nuformix To Develop AV-101 cocrystalline...
VistaGen Therapeutics (NASDAQ:VTGN) has announced an agreement with Nuformix Plc to develop a cocrystalline formulation of AV-101 based ion VistaGen's CNS products for the...
MAKE IT MODERN
LATEST REVIEWS
Nokia’s (NYSE: NOK) New Smartphone is a ‘Military Grade’ Model with...
On July 27, 2020, Nokia (NYSE: NOK) debuted its new devices, including a 'military grade' smartphone designed to withstand severe environmental conditions. According to...
MAKE IT MODERN
PERFORMANCE TRAINING
Vaxart Inc. (NASDAQ: VXRT) Commences Phase II Clinical Trial For its Experimental Oral COVID-19...
A study by Duke University Published in bioRxiv has indicated that Vaxart Inc.’s (NASDAQ: VXRT) experimental oral tablet vaccine can reduce airborne SARS-CoV-2 virus...
Aytu Bioscience Inc (NASDAQ:AYTU) Announces Publication Of Results Of The National Cancer Institute’s Evaluation...
Aytu Bioscience Inc (NASDAQ:AYTU) recently announced that the U.S Food and Drug Administration (FDA) published the findings from the evaluation of its COVID-19 IgG/IgM...
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Announces Important Upcoming Milestones
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) has announced its Q3 2020 results and also offered a corporate update.
BioCryst ready to launch ORLADEYO
Jon Stonehouse, the CEO and...
Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) Commences Treatment Of COVID-19 Patients With New Antibody Activating Approach
Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) commenced the first phase study investigating a proprietary immunotherapy approach for COVID.19 patients. The new method stimulates a patient's immune...
atai Life Sciences ‘(NASDAQ: ATAI) Philanthropic initiative Donates $500,000 To Multidisciplinary Association for Psychedelics
atai Life Sciences ‘(NASDAQ: ATAI) atai Impact, a philanthropic initiative, has announced the award of $500,000 to the Multidisciplinary Association for Psychedelics (MAPS). The...
MAKE IT MODERN
